Effect of Palliative Radiotherapy and Cyclin-Dependent Kinase 4/6 Inhibitor on Breast Cancer Cell Lines

Scientists examined the impact of cyclin-dependent kinase 4/6 inhibitor (CDK 4/6i) and palliative radiation on human breast cancer cell lines.